Buh bye
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Shortly followed by more "the sky is falling" posts.
Right on schedule.
Why do you even care? They are long gone. And why does it even matter? You might as well vent about DOC - same thing.
You used the word "logic". I'd leave it at that.
There is a saying in Mexico...
"Hay mentirosos y hay gente estúpida, no seas ambos."
Ceiling and Floor.
Decide what noun is more relevant with Advaxis.
LOL - glorious! Great analogy
I suppose it all depends on each individual's time frame and expectations set. But, this is not the time to panic (unless you NEED to sell).
No remotely.
My predictions always was caveat-ed with material news - something we have yet to see. Agree that the shorts on hammering this and given the volume, it may very well be them covering.
Once we get something substantial, the pps will never look back.
"Emotion is the wrong foundation for investing"
You can see the board littered with emotional-laced posts based upon the "shock & awe" of the last two trading days. Yah, I get that we're down X%, etc. but nothing has changed. Nothing.
Unless you need to sell today or yesterday or next week or next month, I'm not sure how this matters unless you believe the company is filing Ch. 11. If anything, this maybe an indicator that covering is in full flight, which makes sense given what Lombardo has just stated about the company's "refocus". So, if you can't separate emotion from the day-to-day swings of a highly volatile bio equity like ADXS, you probably shouldn't be investing in the space.
Now is the time for patience, not panic.
Don't play their game.
Like many on this board, reacting emotionally to an unappetizing change in the stock price is EXACTLY what "they" want to happen.
The company is not declaring CH 11, nor have they communicated anything that would lead anybody to believe they are closing their doors within weeks.
Now is the time to do the opposite of the herd.
You have NO idea what you are talking about concerning the EMA process. I will leave it at that.
I don't know what you are expecting given what has been communicated over the last 3 months. Lombardo came and a little later, it was conveyed there would be communications on the company direction September. That has now been communicated. All the other rumors around company buyouts, EU partnerships, etc. discussed on this board are not fact until/if they happen. So, it's just discussion and people sharing opinions, not reality.
Let's see if they deliver EMA submission this year. In the meantime, the bots are in control, plain and simple.
They are still committed for Q4 - that's the best we can expect right now.
1. Lombardo announces company refocusing on: HPV-associated tumors, Prostate Cancer, Neo-epitopes, and Hotspot mutations
2. Market immediately craters the stock 20%, continuing today.
But, the science is still viable as we know it. EMA submission is still on track. EU approval, although not guaranteed, is strongly likely.
Fear is when you buy and there is a lot of fear right now - more than ever. I believe the shorts are covering in lieu of likely material news. This maybe the last time Advaxis is ever this low again.
My $.02
Good plan.
LMAO - I have to laugh at this day. I literally sent an email to IR about the valuation, etc. and got a response about improving shareholder value as the focus and the stock drops 20% - bam. Gotta laugh at it, totally unwarranted and clearly a "sell the news" + shorts making this move with their 100 share bots.
I must admit, they are good at it - for now anyways.
My age? LOL, I can only wish I was half my age! But to answer your question, I'm a long shareholder (about 32k shares, averaged in around ~11). I'm disappointed currently, but very optimistic.
Concerning Lombardo, I think it's very foolish for him to address individual shareholders questions in an email, given the current volatility of the company. Too much risk involved.
Do I think he's lying? Possibly. But more likely, he's responding in a way that can be interpreted in a variety of ways, if you look at the actual versus literal intent of his words. In short, it would serve Advaxis better right now if he would stick to general communications.
And, if the company is really in the process of being sold, they should not respond to emails much at all. Hopefully they know better.
You really think acquisition talks have been in progress?
My opinion. You actually think Advaxis being sold for 1.5-2 B will make the tutes happy? Please.
They have a "DEAL" done huh? Come on man, nobody can know that and announce it without violating SEC rules. I'm as optimistic as anybody about the future, but right now things seem to be somewhat neutral except for the march to EMA submission. Consequently, I've softened my near term expectations.
However, I still believe Advaxis will eventually be acquired for many billions.
Yes, I get that. I've worked for some of the largest companies on the planet and have seen how material news is communicated, etc. The point is, why say anything at all? No need to respond. It's an error in doing so, especially given the context.
I'm not sure they've "landed" an EU partner. That's material and, if so, there will be a PR within 3 days on it. I'm glad to see EMA is still on track for Q4, but I'm less convinced we'll see a partnership before then.
Hoping for the best.
If there is a buyout going on, then Lombardo lied outright to a recent question from an investor. Advaxis is in no position currently to get a price remotely close to reasonable - anything under $50 pps would be thievery.
Hopefully we get some material news before EMA to help move the pps or we're going to be stuck here for a while.
Company is not for sale at the current valuation.
Just got the abstract email from Advaxis:
"Advaxis presents preliminary immune correlative data in prostate"
Unless there wasn't any material news - a possibility
What are you expecting outside of the 10-Q and maybe something out of the conference?
So one thing that I've been reflecting on is the Kite deal and what it could mean to the sector with respect to immunotherapy plays and acquisitions, etc. I'm thinking that event provide a precedence, which will act a major catalyst for future events. Acquisition and/or licensing scenarios will come a significantly higher premium for companies that are starting to land their respective platforms. Advaxis' timing might be just perfect and could ultimately benefit by multiple factors in terms of valuation. In the near future, don't be surprised to see Advaxis suddenly and rapidly climb several billion in valuation over the course of a quarter or less. And that's BEFORE there is any talk about actually being involved in an acquisition.
This could start to happen as early as Q1 of 2018
100k holding claims, you inferring a million shares in jest? I mean a million shares too. And am curious what post storyline will be after Advaxis valuation crosses a billion?
Maybe I misunderstood the thread.
I have serious doubts about legitimacy based upon the content and redundant commentary. It's nonsensical, especially given the breadth of the Advaxis platform.
I find it impossible to defend such a position without losing total credibility. That is my view already.
A million my butt. I wanna read what is said after we blow by the billion-dollar valuation. Probably still talking about DOC and how the valuation would have been higher if DOC hadn't destroyed 40% of the value recently.
So bloody annoying
26% in 12 trading days - no reason
something is up besides the pps...
Yes or not reply. Lot of ways to spin the answer. I guess you could argue that if he intentionally wants to direct differently, the response with rumors coupled with improving shareholder value can be veiling something else.
Really impossible to speculate. Just need to take it for what it is.
The other option is that he is liar, which I hope is not true. At least take the man at this word. He could have easily said nothing.
Possible, but not probable unless the price is very, very good. Unlikely at this early stage. However, it's highly probable that material news is front of us given the "silence". What that news is - who knows?
I've personally backed off on the buyout possibilities near term.
Crazier things have happened though.
"Thank you for reaching out. The company is focused on executing its plan. The entire management team is dedicated to that. The Vision you bought into has not changed. However we will focus our efforts in building shareholder value based on concrete results and in supporting the relationships we have developed
The company will be full engaged in Investor Presentations stating in September. The rumors of things are exactly what they are rumors from individuals who have no knowledge of the company or its activities other than what they want to create or speculate
This process of creating lasting shareholder value is our mission and in supporting our clinical patients and partners
Kind regards
Tony Lombardo"
Fair valuation of $35 or a market cap of ~1.4 billion, which is probably a conservative view as well. We'll get back there and much more before being acquired for double-digit billions.
("thanks Kite for setting the immuno-acquisition bar")
< 3 years
After the pps climbs back to beyond $15 (likely shortly) and the buyout rumors subside, please stop with the following, nonsensical redundant assertions and commentary:
1. Advaxis will be bought for around 1 billion
2. DOC destroyed the value of the company
If you do not, you will be validating what many already think concerning
motivations and intentions. BTW, there is a post on the Facebook board that shuts down all of the nonsense and rumors.
It's a direct email from Lombardo to an investor.
Lots of buzz tonight! Folks hopeful for big news soon? Something about a little birdie and Monday?
??